Skip to Main Content

Author Details

Bert W O'Malley
Center for Coregulator Research, Baylor College of Medicine
1964
1068
147
PMIDPaper TitleJournal TitlePublished Year
35929639In-Hospital Costs for Open versus Endoscopic Endonasal Approach for Craniopharyngioma Resection.Laryngoscope2023
35929639In-Hospital Costs for Open versus Endoscopic Endonasal Approach for Craniopharyngioma Resection.Laryngoscope2023
35473389Post-operative Monitoring for Head and Neck Microvascular Reconstruction in the Era of Resident Duty Hour Restrictions: A Retrospective Cohort Study Comparing 2 Monitoring Protocols.Ann Otol Rhinol Laryngol2023
37676964Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors.Science2023
37962238Steroid receptor coactivator-2 drives epithelial reprogramming that enables murine embryo implantation.FASEB J2023
37155905TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer.Proc Natl Acad Sci U S A2023
36656865Enhancer-promoter entanglement explains their transcriptional interdependence.Proc Natl Acad Sci U S A2023
36640831Implementation of a Streamlined Care Pathway to Reduce Cost and Length of Stay for Patients Undergoing Endoscopic Transsphenoidal Pituitary Surgery.World Neurosurg2023
36945511Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.Res Sq2023
37253006Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion.Proc Natl Acad Sci U S A2023
36529537In-Hospital Cost Comparison for Open Versus Endoscopic Endonasal Approach for Meningioma Resection.Am J Rhinol Allergy2023
37034717Steroid Receptor Coactivator-3 is a Key Modulator of Regulatory T Cell-Mediated Tumor Evasion.bioRxiv2023
37962238Steroid receptor coactivator-2 drives epithelial reprogramming that enables murine embryo implantation.FASEB J2023
37676964Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors.Science2023
35473389Post-operative Monitoring for Head and Neck Microvascular Reconstruction in the Era of Resident Duty Hour Restrictions: A Retrospective Cohort Study Comparing 2 Monitoring Protocols.Ann Otol Rhinol Laryngol2023
37155905TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer.Proc Natl Acad Sci U S A2023
37253006Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion.Proc Natl Acad Sci U S A2023
36945511Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.Res Sq2023
37034717Steroid Receptor Coactivator-3 is a Key Modulator of Regulatory T Cell-Mediated Tumor Evasion.bioRxiv2023
36656865Enhancer-promoter entanglement explains their transcriptional interdependence.Proc Natl Acad Sci U S A2023
36640831Implementation of a Streamlined Care Pathway to Reduce Cost and Length of Stay for Patients Undergoing Endoscopic Transsphenoidal Pituitary Surgery.World Neurosurg2023
36529537In-Hospital Cost Comparison for Open Versus Endoscopic Endonasal Approach for Meningioma Resection.Am J Rhinol Allergy2023
34510780Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma.Int Forum Allergy Rhinol2022
36302835Subclinical diagnosis of cisplatin-induced ototoxicity with biomarkers.Sci Rep2022
35942327Financial impact of the COVID-19 pandemic on an academic otolaryngology department.World J Otorhinolaryngol Head Neck Surg2022
36209822Aging-associated REGγ proteasome decline predisposes to tauopathy.J Biol Chem2022
36325049Spatial definition of the human progesterone receptor-B transcriptional complex.iScience2022
35986082Reply to: Target expression is a relevant factor in synthetic lethal screens.Commun Biol2022
36419064Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis.J Biomed Sci2022
36316775Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.Breast Cancer Res2022
36582250Steroid receptor coactivators - their role in immunity.Front Immunol2022
36505394Decidualization of human endometrial stromal cells requires steroid receptor coactivator-3.Front Reprod Health2022
36533127A steroid receptor coactivator small molecule "stimulator" attenuates post-stroke ischemic brain injury.Front Mol Neurosci2022
34510780Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma.Int Forum Allergy Rhinol2022
35245888A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.Oral Oncol2022
34699271Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).J Clin Oncol2022
35263593Defining the mammalian coactivation of hepatic 12-h clock and lipid metabolism.Cell Rep2022
36582250Steroid receptor coactivators - their role in immunity.Front Immunol2022
36505394Decidualization of human endometrial stromal cells requires steroid receptor coactivator-3.Front Reprod Health2022
36533127A steroid receptor coactivator small molecule "stimulator" attenuates post-stroke ischemic brain injury.Front Mol Neurosci2022
36419064Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis.J Biomed Sci2022
36209822Aging-associated REGγ proteasome decline predisposes to tauopathy.J Biol Chem2022
36302835Subclinical diagnosis of cisplatin-induced ototoxicity with biomarkers.Sci Rep2022
35986082Reply to: Target expression is a relevant factor in synthetic lethal screens.Commun Biol2022
36325049Spatial definition of the human progesterone receptor-B transcriptional complex.iScience2022
36316775Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.Breast Cancer Res2022
35942327Financial impact of the COVID-19 pandemic on an academic otolaryngology department.World J Otorhinolaryngol Head Neck Surg2022
35245888A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.Oral Oncol2022
35263593Defining the mammalian coactivation of hepatic 12-h clock and lipid metabolism.Cell Rep2022
34699271Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).J Clin Oncol2022
  • 1 - 50 of 2,136

Recommended Authors

National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
Genomics Institute of the Novartis Research Foundation
Career Start Year 1995
Number of shared co-authors 1
Seragon Pharmaceuticals, Inc.
Career Start Year 1994
Number of shared co-authors 1
Fudan University Shanghai Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Massey Cancer Center, Virginia Commonwealth University
Career Start Year 1992
Number of shared co-authors 0
Shandong Management University
Career Start Year 1992
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 1991
Number of shared co-authors 0
Westmead Institute for Medical Research
Career Start Year 1990
Number of shared co-authors 0
CellFree Sciences Co.
Career Start Year 1989
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1988
Number of shared co-authors 1
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 0
Osaka University
Career Start Year 1987
Number of shared co-authors 1
Western University
Career Start Year 1985
Number of shared co-authors 2
Princess Maxima Center for Pediatric Oncology Research
Career Start Year 1983
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1983
Number of shared co-authors 0
Medical University of South Carolina
Career Start Year 1982
Number of shared co-authors 7
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 4
Mayo Clinic Rochester
Career Start Year 1979
Number of shared co-authors 1
Westmead Institute for Medical Research, University of Sydney
Career Start Year 1978
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 0
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 1
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year 1974
Number of shared co-authors 2
Institut de recherches cliniques de Montreal (IRCM)
Career Start Year 1974
Number of shared co-authors 1
Vollum Institute, Oregon Health & Science University
Career Start Year 1973
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1973
Number of shared co-authors 5
National Institutes of Health
Career Start Year 1972
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1969
Number of shared co-authors 3
University of Vermont
Career Start Year 1968
Number of shared co-authors 2
College des medecins du Quebec
Career Start Year 1968
Number of shared co-authors 0
Sao Paulo University
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Center for Coregulator Research, Baylor College of Medicine
Co-authored papers 54
Co-authored papers 39
Co-authored papers 27
Co-authored papers 26
Co-authored papers 25
Co-authored papers 25
Co-authored papers 18
Baylor College of Medicine
Co-authored papers 18
Co-authored papers 17
Co-authored papers 16
Co-authored papers 12
Co-authored papers 11
Co-authored papers 10
Co-authored papers 9
Duke Molecular Physiology Institute
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Rutgers New Jersey Medical School
Co-authored papers 6
Children's Hospital of Philadelphia
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 5
Co-authored papers 4
Duke Molecular Physiology Institute
Co-authored papers 4
2Mayo Clinic
Co-authored papers 4
Co-authored papers 4
David Geffen School of Medicine, university of california los angeles
Co-authored papers 4
Co-authored papers 4